Amedica Corporation (AMDA) Shares are Up 8.44%

Amedica Corporation (AMDA) has been under a strong bear grip, hence the stock is down -39.26% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 8.51% in the past 1 week. The stock has risen by 8.44% in the past week indicating that the buyers are active at lower levels, but the stock is down -37.22% in the past 4 weeks.

The stock has recorded a 20-day Moving Average of 5.46% and the 50-Day Moving Average is 28.95%. Amedica Corporation has dropped 46.47% during the last 3-month period . Year-to-Date the stock performance stands at -53.22%.


Amedica Corporation (NASDAQ:AMDA): On Fridays trading session , Opening price of the stock was $0.96 with an intraday high of $0.96. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $0.8. However, the stock managed to close at $0.835, a loss of 3.86% for the day. On the previous day, the stock had closed at $0.8685. The total traded volume of the day was 2,378,858 shares.

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer focused on using its silicon nitride technology platform to develop, manufacture and sell a range of medical devices. The Company markets spinal fusion products and are developing products for use in total hip and knee joint replacements. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States and Europe for use in the cervical and thoracolumbar areas of the spine. The Companys Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Cervical and Corpectomy. In addition to its silicon nitride-based spinal fusion products, the Company markets a line of non-silicon nitride spinal fusion products, which allows it to provide surgeons and hospitals with a range of products.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.